China Overturns Pfizer's Viagra Patent

Law360, New York (July 7, 2004, 12:00 AM EDT) -- In a stinging blow to Pfizer, the patent re-examination board of China's State Intellectual Property Office has overturned the company's patent for erectile dysfunction drug Viagra.

In a statement, Pfizer said it was “extremely disheartened by this recent action." The U.S. drug maker said it would appeal, and that its China patent for the anti-impotence drug would remain in effect while it appeals.

SIPO approved Pfizer's patent application for its anti-impotency drug Viagra in late 2001.

But shortly after the patent was approved, twelve of the...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.